Effect of Insulin Resistance on the Safety and Efficacy of Pegylated Interferon and Ribavirin Treatment in HCV (Study P05562)
Clinical trial NCT00705224 · COMPLETED
Trial details
- NCT number
- NCT00705224
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2008-05-01
- Primary completion
- 2010-08-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.